These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 29322838)
1. Chronic myelomonocytic leukemia with central nervous system involvement. Hannon M; Wilde L; Nwaoduah N; Kasner M Leuk Lymphoma; 2018 Sep; 59(9):2267-2268. PubMed ID: 29322838 [No Abstract] [Full Text] [Related]
2. Azacitidine followed by radiotherapy as effective treatment for chronic myelomonocytic leukemia with extramedullary localization. Serrao A; Loglisci G; Salaroli A; Zacheo I; Alimena G; Breccia M Leuk Lymphoma; 2013 Feb; 54(2):411-2. PubMed ID: 22694794 [No Abstract] [Full Text] [Related]
3. Haploidentical stem cell transplantation in patients with chronic myelomonocytic leukemia. Sun YQ; Zhao C; Wang Y; Yan CH; Zhang XH; Xu LP; Liu KY; Huang XJ Sci China Life Sci; 2020 Aug; 63(8):1261-1264. PubMed ID: 32086671 [No Abstract] [Full Text] [Related]
4. Central nervous system relapse of primary cutaneous CD8 Oun H; Wilson M; Leach M; McKay P Br J Haematol; 2021 Apr; 193(1):9. PubMed ID: 33336793 [No Abstract] [Full Text] [Related]
5. [The trial use of alpha-IFN in treating a case of chronic myelomonocytic leukemia with splenic infarction]. Kimura S; Yokoo K; Ozawa M; Kobayashi Y; Horiuchi H; Kondo M Gan No Rinsho; 1989 Apr; 35(5):615-9. PubMed ID: 2716192 [TBL] [Abstract][Full Text] [Related]
6. Chronic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia: a way to improve the outcome? Niscola P; Cupelli L; Dentamaro T; de Fabritiis P Leuk Res; 2016 Mar; 42():80-1. PubMed ID: 26790726 [No Abstract] [Full Text] [Related]
7. [Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia]. Shao Q; Wang ZD; Zheng XL; Dong L; Han DM; Yan HM; Wang HX; Duan LN Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1058-62. PubMed ID: 25130828 [TBL] [Abstract][Full Text] [Related]
8. Dismal outcome of acute myeloid leukemia secondary to myelodysplastic syndrome and chronic myelomonocytic leukemia after azacitidine failure in a daily-life setting. Niscola P; Tendas A; Cupelli L; Giovannini M; Piccioni D; Scaramucci L; Dentamaro T; Del Poeta G; de Fabritiis P Acta Haematol; 2015; 133(1):64-6. PubMed ID: 25139255 [No Abstract] [Full Text] [Related]
18. Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia. Pophali P; Matin A; Mangaonkar AA; Carr R; Binder M; Al-Kali A; Begna KH; Reichard KK; Alkhateeb H; Shah MV; Tefferi A; Hogan WJ; Litzow MR; Patnaik MM Blood Cancer J; 2020 Nov; 10(11):121. PubMed ID: 33219206 [No Abstract] [Full Text] [Related]
19. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement. Castagnola C; Nozza A; Corso A; Bernasconi C Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724 [TBL] [Abstract][Full Text] [Related]
20. Central nervous system involvement in T-cell lymphoma: A single center experience. Gurion R; Mehta N; Migliacci JC; Zelenetz A; Moskowitz A; Lunning M; Moskowitz C; Hamlin P; Horwitz S Acta Oncol; 2016 May; 55(5):561-6. PubMed ID: 27046135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]